Highest development stage: Preclinical

Development status: Inactive

Gram-positive activity

Gram-negative activity

Mechanism of Action/Target pathogen: The base compound was synthesised from 3, 5-dichloroanisole which was then chemically manipulated to generate a number of analogs. Many demonstrated toxicity. The less chlorinated analogue had broad spectrum activity and reduced toxicity.